Skip to main content

Table 1 Characteristics of patients and controls

From: LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications

Controls(187) Sex*  
      Male, N(%) 157(83.9%)
      Female,(N%) 30(16.1%)
   Mean Age# 45.5 ± 5.2
HNSCC & Dysplastic lesions(147) Sex*  
      Male, N(%) 110(74.8%)
      Female,(N%) 37(25.2%)
   Mean Age# 52 ± 6.4
   Lymp Node Positive 26(17.7%)
   Lymp Node Negative 121(82.3%)
   Tobacco User 103(70%)
   Tobacco free 44(30%)
   Alcohol User 13(8.8%)
   Alcohol free 134(91.2%)
HNSCC (110) Oral Cavity tumors(85) Buccal Mucosa, N(%) 32(29.1%)
   Tongue, N(%) 13(11.8%)
   Cheek, N(%) 19(17.3%)
   Lip, N(%) 3(2.7%)
   Tonsil, N(%) 4(3.6%)
   Palate, N(%) 2(1.8%)
   Alveolus, N(%) 11(10%)
   Vocal cord, N(%) 1(0.9%)
  Laryngeal Tumors(12) & Larynx, N(%) 12(10.9%)
  Nasopharyngeal Tumor(3) Nassopharynx, N(%) 3(2.7%)
  Orofacial Tumors(10) Maxilla, N(%) 5(4.5%)
   Mandible, N(%) 5(4.5%)
  Histopathology(110) StageI 15(14%)
   StageII 30(27%)
   StageIII 34(31%)
   StageIV 31(28%)
Dysplastic lesions (37)   Buccal Mucosa, N(%) 37(100%)
  Histopathology(37) Mild Dysplasia 5(13.5%)
   Moderate Dysplasia 19(51.4%)
   Severe Dysplasia 13(35.1%)
  1. * Difference in sex distribution: Control vs. HNSCC, P = 0.04,
  2. # Mean age difference: Control vs. HNSCC, P = 0.01.